Oncology Imaging Leader: PET Biomarker Strategy & Endpoints
Listed on 2026-10-20
-
Pharmaceutical
-
Healthcare
Regeneron Pharmaceuticals Inc. seeks a Clinical Imaging Scientific Director for Oncology to own the strategy and execution of advanced oncology imaging in clinical trials, with emphasis on PET and CT, imaging endpoints, and biomarkers.
The role leads cross-functional teams, presents strategies to senior management, and ensures data integrity across Regeneron and external partners. On-site work with multi-site collaboration is expected.
This role is for the Oncology Imaging Leader: PET Biomarker Strategy & Endpoints role at Regeneron Pharmaceuticals Inc.
Learn more about the Oncology Imaging Leader: PET Biomarker Strategy & Endpoints role in the description above.
We appreciate your interest in this position.
Join Regeneron Pharmaceuticals Inc. and contribute to our ongoing work.
Take a moment to read everything above and see whether this role is right for you.
This posting is for the Oncology Imaging Leader: PET Biomarker Strategy & Endpoints role at Regeneron Pharmaceuticals Inc., based in Cambridge, MA, United States.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).